Authors
Loading...
Network meta-analysis reveals combined bulevirtide and PEG-IFN-alpha improves virological outcomes in HDV patients.
Ouranos et al. (2025) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: